Linked Life Data

16919735

Source:http://linkedlifedata.com/resource/pubmed/id/16919735

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2006-8-21
pubmed:abstractText
Many parolees and probationers are opioid abusers, and substance abuse is a leading factor for the revocation of probation, parole, and other alternatives to incarceration. The opioid antagonist naltrexone would appear to be an excellent treatment for opioid abuse and dependence in this population and the authors sought to systematically review this literature. Using the PubMed database, the authors identified large bodies of criminal justice (CJS) and naltrexone literature. The search terms used in both searches were crosschecked to identify all articles that involved research on naltrexone in the CJS. Only two articles were identified. The lack of research on naltrexone in the criminal justice system highlights the need for more research on naltrexone in our overburdened CJS.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0740-5472
pubmed:author
pubmed:issnType
Print
pubmed:volume
31
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
113-5
pubmed:meshHeading
pubmed:year
2006
pubmed:articleTitle
Research on naltrexone in the criminal justice system.
pubmed:affiliation
Treatment Research Institute at the University of Pennsylvania, Philadelphia, 19106-3475, USA. npatapis@tresearch.org
pubmed:publicationType
Journal Article, Review